Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide

EMBO Journal

Volumn 15, Issue 6, 1996, Pages 1283-1291

  Schöneberg, Torsten ^a   Yun, June ^a   Wenkert, David ^a   Wess, Jürgen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Co expression experiments; Nephrogenic diabetes insipidus; Receptor mutagenesis; Receptor peptide; V2 vasopressin receptor

Indexed keywords

POLYPEPTIDE; RADIOLIGAND; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONTROLLED STUDY; DELETION MUTANT; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; MISSENSE MUTATION; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN FOLDING; RECEPTOR BINDING; RECEPTOR DENSITY;

ANIMALIA;

EID: 0030006129     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb00470.x     Document Type: Article

References (38)

1. Bichet, D.G. et al. (1993) X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J. Clin Invest., 92, 1262-1268.
2. Bichet, D.G. et al. (1994) Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am. J. Hum. Genet., 55, 278-286
3. Birnbaumer, M. (1995) Mutations and diseases of G protein coupled receptors. J. Rec. Sign. Transduct. Res., 151, 131-160.
4. Birnbaumer, M., Seibold, A , Gilbert, S., Ishido, M., Barberis, C., Antaramian, A., Brabet, P. and Rosenthal, W. (1992) Molecular cloning of the receptor for human antidiuretic hormone. Nature, 357, 333-335
5. Bonner, T.I., Young, A C., Brann, M.R. and Buckley, N.J. (1988) Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron, 1, 403-410.
6. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem., 72, 248-254.
7. Chini, B. et al. (1995) Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO J., 14, 2176-2182.
8. Coughlin, S.R (1994) Expanding horizons for receptors coupled to G proteins: diversity and disease. Curr. Opin. Cell Biol., 6, 191-197.
9. Cullen, B.R. (1987) Use of eucaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol., 152, 684-704
10. Dohlman, H.G., Thorner, J., Caron, M.G. and Lefkowitz, R.J. (1991) Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem., 60, 653-688.
11. Dörje, F., Wess, J., Lambrecht, G., Tacke, R , Mutschler, E. and Brann, M.R (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther., 256, 727-733.
12. Higuchi, R. (1989) Using PCR to engineer DNA. In Erlich, H.A. (ed.). PCR Technology. Stockton Press, New York, pp. 61-70.
13. Kahn, T.W. and Engelman, D M. (1992) Bacteriorhodopsin can be refolded from two independentiy stable transmembrane helices and the complementary five-helix fragment. Biochemistry, 31, 6144-6151.
14. Kitamura, M. (1994) Transfer of exogenous gens into the kidney. Exp Nephrol., 2, 313-317
15. Klausner, R.D and Sitia, R. (1990) Protein degradation in the endoplasmic reticulum. Cell, 62, 611-614.
16. 2-adrenergic receptors delineation of domains involved in effector coupling and ligand binding specificity. Science, 240, 1310-1316.
17. Kolodziej, P.A. and Young, R.A. (1991) Epitope tagging and protein surveillance. Methods Enzymol., 194, 508-519.
18. Laszlo, F.A., Laszlo, F , Jr and De Wied, D. (1991) Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol. Rev., 43, 73-108.
19. Maggio, R , Vogel, Z. and Wess, J. (1993a) Reconstitution of functional muscarinic receptors by coexpression of amino and carboxyl terminal receptor fragments. FEBS Lett., 319, 195-200.
20. Maggio, R., Vogel, Z. and Wess, J. (1993b) Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular crosstalk between G protein-linked receptors. Proc. Natl Acad. Sci. USA, 90, 3103-3107.
21. Munson, P.J. and Rodbard, D. (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239.
22. Pan, Y., Wilson, P. and Gitschter, J. (1994) The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin. J. Biol. Chem., 269, 31933-31937.
23. Popot, J.-L. and Engelmann, D M. (1990) Membrane folding and oligomerization: the two-stage model. Biochemistry. 29, 4031-4037.
24. Raymond, J.R. (1994) Hereditary and acquired defects in signaling through hormone-receptor-G protein complex. Am. J. Physiol., 266, F163-F174
25. Ridge, K.D., Lee, S.S.J. and Yao, L.L. (1995) In vivo assembly of rhodopsin from expressed polypeptide fragments. Proc. Natl Acad. Sci. USA, 92, 3204-3208.
26. Rosenthal, W., Seibold, A., Antaramian, A., Lonergan, M., Arthus, M.-F , Hendy, G.N., Birnbaumer, M. and Bichet, D.G. (1992) Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature, 359, 233-235.
27. Salomon, Y., Londos, C. and Rodbell, M. (1974) A highly sensitive adenylate cyclase assay. Anal. Biochem., 58, 541-548
28. Sanger, F., Nicklen, S. and Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA, 74, 5463-5467.
29. Schoneberg, T., Liu, J. and Wess, J. (1995) Plasma membrane localization and functional rescue of truncated forms of a G protein-coupled receptor J. Biol. Chem., 270, 18000-18006.
30. Spiegel, A M. (1996) Defects in G protein-coupled signal transduction in human disease. Annu. Rev. Physiol, in press.
31. Strader, C.D , Fong, T.M., Tota, M.R., Underwood, D. and Dixon, R.A.F. (1994) Structure and function of G protein-coupled receptors. Annu. Rev. Biochem., 63, 101-132.
32. Strosberg, A.D (1991) Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. Eur. J Biochem., 196, 1-10.
33. Sung, C.-H., Schneider, B.G , Agarwal, N., Papermaster, D.S. and Nathans, J (1991) Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc. Natl Acad. Sci. USA, 88, 8840-8844
34. Tsukaguchi, H., Matsubara, H., Aritaki, S , Kimura, T., Abe, S. and Inada, M. (1993) Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Biochem Biophys. Res. Commun., 197, 1000-1010.
35. Tsukaguchi, H., Matsubara, H., Mori, Y., Yohsimasa, Y., Yohsimasa, T., Nakao, K. and Inada, M. (1995) Two vasopressin type 2 receptor gene mutations R143P and ΔV278 in patients with nephrogenic diabetes insipidus impair ligand binding of the receptor. Biochem. Biophys. Res. Commun., 211, 967-977.
36. Watson, S. and Arkinstall, S. (1994) The G-Protein Linked Receptor - Facts Book. Academic Press, London, UK.
37. Wenkert, D., Merendino, J.J.,Jr, Shenker, A., Thambi, N., Robertson, G.L., Moses, A.M. and Spiegel, A.M (1994) Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus. Hum. Mol. Genet., 3, 1429-1430.
38. Wildin, R.S., Antush, M.J., Bennett, R.L., Schoof, J.M. and Scott, C.R. (1994) Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am. J. Hum. Genet., 55, 266-277.